Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13 скачать в хорошем качестве

Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13

Medical oncologist Mark Scholz, MD answers patient's questions from our YouTube comments on the topics of active surveillance for Gleason 3+4=7 (favorable intermediate-risk) in relatively younger patients, BPH procedures when Gleason 3+3=6 (low-risk) is present, breast enlargement from finasteride (Proscar) and dutasteride (Avodart), how long an intermediate-risk patient can delay treatment, and SBRT versus radiation seed implants. 0:06 I am 49 with Gleason 3+4 prostate cancer. My doctors are recommending immediate treatment because of my age. Is active surveillance an option for someone my age in this situation? 2:11 Can patients get genetic testing from their general practitioner/family physician? 3:27 How does low-grade Gleason 6 prostate cancer affect options for BPH procedures? 4:15 What is the risk of breast enlargement from finasteride? 4:55 How long can a man with Basic Teal (intermediate-risk) prostate cancer delay treatment? 5:31 Which is better for a Low-Teal Gleason 3+4 (favorable intermediate-risk) patient: SBRT or radioactive seed implants? Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org To learn more about prostate cancer visit http://www.pcri.org Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #MarkScholzMD #Prostate